Effects of angiotensin converting enzyme inhibition on endothelium-dependent vasodilatation in essential hypertensive patients

Journal of Hypertension

Volumn 16, Issue 4, 1998, Pages 447-456

  Taddei, Stefano ^a   Virdis, Agostino ^a   Ghiadoni, Lorenzo ^a   Mattei, Paola ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Angiotensin converting enzyme inhibition; Endothelium; Endothelium derived factors; Hypertension; Nitric oxide

Indexed keywords

ACETYLCHOLINE; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; NITROPRUSSIDE SODIUM;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0031956678     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816040-00006     Document Type: Article

References (52)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-376.
2. Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton, Florida: CRC Press; 1990.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release amounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
4. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:664-666.
5. Linder L, Kiowski W, Bühler, Lüscher TF. Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990; 81:1762-1767.
6. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-27.
7. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993; 21:929-933.
8. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87:1468-1474.
9. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87:1475-1481.
10. Taddei S, Virdis A, Mattel P, Ghiadoni L, Gennari A, Basile Fasolo C, et al. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation 1995; 91:1981-1987.
11. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 1995; 92:2911-2918.
12. Taddei S, Virdis A, Mattei P, Ghiadoni L, Basile Fasolo C, Sudano I, et al. Hypertension causes premature aging of endothelial function in humans. Hypertension 1997; 29:736-743.
13. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi A, Cannon RO III. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localised to a single signal transduction pathway. Circulation 1995; 91:1732-1738.
14. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62:347-504.
15. Morishita R, Higaki J, Miyazaki M, Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension 1992; 19 (suppl II):II62-II67.
16. Erdös EG, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest 1987; 56:345-348.
17. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 1990; 16:532-540.
18. Takase H, Moreau P, Küng CF, Nava E, Lüscher TF. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension 1996; 27:25-31.
19. Antony I, Lerebours G, Nitenberg A. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. Circulation 1996; 94:3115-3122.
20. Mimran A, Ribstein J, DuCailar G. Contrasting effect of antihypertensive treatment on the renal response to L-arginine. Hypertension 1995; 26:937-941.
21. Hirooka Y, Imaizumi T, Masaki H, Aando S, Harada S, Momohera M, et al. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension 1992; 20:175-180.
22. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension 1994; 24:499-505.
23. Kiowski W, Linder L, Nuesch R, Martina B. Effect of cilazapril on vascular structure and function in essential hypertension. Hypertension 1996; 27:371-376.
24. Folkow B. The structural factor in hypertension with special emphasis on the altered geometric design of the systemic arteries. In: Laragh JH and Brenner BM (editors): Hypertension: pathophysiology. diagnosis and treatment. New York: Raven Press Publishers; 1995. pp. 481-502.
25. Pedrinelli R, Taddei S, Spessot M, Salvetti A. Maximal postischemic forearm vasodilation in human hypertension: a reassessment of the method. J Hypertens 1987; 5 (suppl 5):S431-S433.
26. Agabiti-Rosei E, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, et al. Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995; 13:341-347.
27. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond) 1953; 121:1-27.
28. Pedrinelli R, Taddei S, Graziadei L, Salvetti A. Vascular responses to ouabain and norepinephrine in low and normal renin hypertension. Hypertension 1986; 8:786-792.
29. Devereux RB, Alonso DR, Lertas EM, Gottlib GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular mass: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
30. Schultz KD, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature 1977; 265:750-751.
31. Malvano R, Zumlhelli GC, Rosa U, Salvetti A. Measurement of plasma renin activity by angiotensin I radioimmunoassay (I): an assessment of some methodological aspects. J Nucl Biol Med 1972; 16:24-31.
32. Lieberman J. Elevation of serum angiotensm-converting enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59:365-372.
33. Zeiher MA, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest 1993; 92:652-662.
34. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, et al. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993; 88:77-81.
35. Lüscher T. The endothelium in hypertension: bystander, target or mediator? J Hypertens 1994; 12 (suppl 10):S105-S116.
36. Dzau VJ, Gibbons G. Does hypertension potentiates atherosclerosis via vascular hypertrophy? J Cardiovasc Pharmacol 1991; 17:34-37.
37. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possess pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61:866-879.
38. Vanhoutte PM, Auch-Schwelk W, Biondi ML, Lorenz RR, Schini VB, Vidai MJ. Why are converting enzyme inhibitors vasodilators? Br J Clin Pharmacol 1989; 28:95S-104S.
39. Kerth PA, Vanhoutte PM. Effects of perindoprilat on endothelium-dependent relaxations and contractions in isolated blood vessels. Am J Physiol 1990; 4:226S-234S.
40. Mombouli JV, Nephtali M, Vanhoutte PM, Effects of the non sulfhydryl angiotensin I converting enzyme inhibitor cilazaprilat on endothelium-dependent responses in isolated canine arteries. Hypertension 1991; 18 (suppl II):II12-II29.
41. Benjamin N, Cockcroft JR, Collier JG, Dollery CT, Ritter JM. Webb DJ. Local ACE inhibition modulates vascular responses to angiotensin and bradykinin in the human forearm. J Physiol 1989; 412:543-555.
42. Schiffrin EL, Deng Li-Y, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23:83-91.
43. Schiffrin EL, Deng Li-Y: Comparison of effects of angiotensin I-converting enzyme inhibition and β-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995; 25:699-703.
44. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli R, Bettoni G, et al. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens 1997; 15:197-204.
45. Mancini GBJ, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, et al. Angiotensin converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 1996; 94:258-265.
46. Virdis A, Ghiadoni L, Lucarini A, Di Legge V, Taddei S, Salvetti A. Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment. Am J Hypertens 1996; 9:361-369.
47. Thybo NK, Stephens N, Cooper A, Aalkjær C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25:474-481.
48. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a β-blocker. Am J Hypertens 1995; 8:229-236.
49. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction in normotensive and essential hypertensive humans. Hypertension 1996; 28:576-582.
50. Schachter M. Kallikreins (kininogenases) - a group of serine proteases with biregulatory actions. Pharmacol Rev 1980; 31:1-17.
51. Nolly H, Scicli AG, Scicli G, Carrettero OA. Characterization of a chininogenase from rat vascular tissue resembling tissue kallikrein. Circ Res 1985; 56:816-821.
52. Oza NB, Schwartz JH, Goud HD, Levinsky NG. Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity, J Clim Invest 1990; 85:597-600.